Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial
一项III期随机、双盲对照试验，比较了每日一次、连续3天口服萘菲霉素方案与口服莫西沙星治疗成人社区获得性细菌性肺炎的疗效和安全性。
期刊:Lancet Regional Health - Southeast Asia
影响因子:6.2
doi:10.1016/j.lansea.2025.100666
Pophale, Himanshu; Gupta, Monica; Llorens, Lily; Iwanowski, Piotr; Gutte, Ranjeet; Chavan, Rajesh; Patel, Anasuya; Agrawal, Harsha; Palwe, Snehal; Joshi, Prashant; Periasamy, Hariharan; Patel, Mahesh; Veeraraghavan, Balaji; Bhagwat, Sachin
